All posts by student

Merck’s Immunology and Cardiovascular Franchise in 1Q17 – Market … – Market Realist

Merck & Co.s Recent Developments and Valuations PART 10 OF 11

Merck & Co.s (MRK) Immunology franchise includes Remicade and Simponi. Remicade is one of the top-selling drugs for the treatment of inflammatory disorders, while Simponi is a once-monthly subcutaneous treatment. Both drugs reported a decline in revenues during 1Q17.

Remicades revenues fell ~34% to $229 million in 1Q17, compared to $349 million for 1Q16. This decline was due to the entry of generic competition and biosimilars following the loss of exclusivity of Remicade in the European markets in February 2015. Merck expects Remicades revenues to continue their declines, as new patients prefer biosimilars over Remicade.

While Merck has the marketing rights for Remicade in the European markets, Johnson & Johnson (JNJ) holds marketing rights of Remicade in several countries outside Europe.

Simponis revenues fell to $184 million in 1Q17, compared to $188 million in 1Q16.

Mercks Cardiovascular franchise includes the blockbuster drugs Zetia and Vytorin. These drugs are used for lowering the LDL cholesterol levels in the blood of patients with a high risk of cardiovascular disease.

The combined revenues for Zetia and Vytorin fell 35% to $575 million in 1Q17, compared to $889 million in 1Q16. Zetia competes with AbbVies (ABBV) Niaspan and Pfizers (PFE) Lipitor.

To divest company-specific risks, investors can consider the iShares Core High Dividend ETF (HDV), which holds ~3.5% of its total assets in Merck. HDV also holds 4.9% in Pfizer (PFE) and 1.5% in Eli Lilly & Co. (LLY).

Read the original:
Merck's Immunology and Cardiovascular Franchise in 1Q17 - Market ... - Market Realist

Anind K. Dey named dean of the UW’s Information School – UW Today

Administrative affairs | Education | For UW employees | News releases

June 29, 2017

Anind K. Dey has been named dean of the Information School at the University of Washington, President Ana Mari Cauce and Provost Jerry Baldasty announced this week. Dey comes to the UW from Carnegie Mellon University School of Computer Science, where he is the Charles M. Geschke professor and director of the Human-Computer Interaction Institute. His appointment is subject to approval by the UW Board of Regents.

Anind K. Dey

Anind brings great knowledge, insight and experience to the iSchool and the UW, Baldasty said. We are confident that he will build on the remarkable work by Dean Emeritus Mike Eisenberg and Dean Harry Bruce, whose combined vision and leadership has helped make the iSchool one of the premier schools of its kind in the country.

Bruce announced earlier this year his decision to step down as dean. This spring, U.S. News & World Report ranked the iSchool second among U.S. masters degree programs in library and information science.

In his research, Dey uses everyday technology (worn, carried and embedded in the environment) to develop tools and techniques for understanding and modeling human behavior, primarily within the areas of health, transportation, sustainability and education. Some of his work has involved using sensors to collect information on the activities of older people that could be used to better personalize their health care.

Dey has been a professor at Carnegie Mellon since 2005. He has also held positions at Intel Research in Berkeley from 2001 to 2004, and at the University of California, Berkeley, from 2002 to 2005.

Anind earned his bachelors degree in computer engineering from Simon Fraser University in Canada. He holds two masters degrees from the Georgia Institute of Technology one in aerospace engineering and one in computer science. He received his Ph.D. in computer science, also from the Georgia Institute of Technology.

Originally posted here:
Anind K. Dey named dean of the UW's Information School - UW Today

Scientists identify link between gut microbiota and mood, behavior – News-Medical.net

June 29, 2017

FINDINGS

Researchers have identified gut microbiota that interact with brain regions associated with mood and behavior. This may be the first time that behavioral and neurobiological differences associated with microbial composition in healthy humans have been identified.

BACKGROUND

Brain-gut-microbiota interactions may play an important role in human health and behavior. Previous research suggests that microbiota, a community of microorganisms in the gut, can influence behavior and emotion. Rodent models have demonstrated the effects of gut microbiota on emotional and social behaviors, such as anxiety and depression. There is, however, little evidence of this in humans.

For this study the researchers sought to identify brain and behavioral characteristics of healthy women clustered by gut microbiota profiles.

METHOD

Forty women supplied fecal samples for profiling, and magnetic resonance images were taken of their brains as they viewed images of individuals, activities or things that evoked emotional responses. The women were divided by their gut bacteria composition into two groups: 33 had more of a bacterium called Bacteroides; the remaining seven had more of the Prevotella bacteria. The Bacteroides group showed greater thickness of the gray matter in the frontal cortex and insula, brain regions involved with complex processing of information. They also had larger volumes of the hippocampus, a region involved in memory processing. The Prevotella group, by contrast, showed more connections between emotional, attentional and sensory brain regions and lower brain volumes in several regions, such as the hippocampus. This group's hippocampus was less active while the women were viewing negative images. They also rated higher levels of negative feelings such as anxiety, distress and irritability after looking at photos with negative images than did the Bacteroides group.

IMPACT

These results support the concept of brain-gut-microbiota interactions in healthy humans. Researchers do not yet know whether bacteria in the gut influence the development of the brain and its activity when unpleasant emotional content is encountered, or if existing differences in the brain influence the type of bacteria that reside in the gut. Both possibilities, however, could lead to important changes in how one thinks about human emotions.

Original post:
Scientists identify link between gut microbiota and mood, behavior - News-Medical.net

Scanalytics wins Cisco award – BizTimes.com (Milwaukee)

Milwaukee-based startup Scanalytics Inc. has earned a top award from technology giant Cisco in an IoT for Business development competition.

Joe Scanlin and Matt McCoy founded Milwaukee startup Scanalytics.

Scanalytics, which developed smart flooring technology, earned a first place in the Best Smart Building technology category in the contest, which was held this month at Viva Technology 2017 in Paris. More than 5,000 startups and 68,000 people attended Viva Technology.

Scanalytics has developed a sensor-based engagement and analytics platform that monitors human behavior through foot traffic and predictive analytics. Among the uses the company has tested are retail product sales, in which a salesperson could be alerted if a customer is standing near a product, and business conferences, in which organizers can track booth traffic. The company deployed sensors to more than 100 clients globally in 2016.

Cisco and Scanalytics have now collaborated to create a new use for the smart flooring technology. Joe Scanlin, chief executive officer of Scanalytics, and Petr Bambasek, director of product, worked with Cisco engineers to link its technology to Ciscos Spark cloud collaboration program.

The team created a product through which a chat bot pulls data from Scanalytics application programming interface in real time, and communicates it to a buildings occupants via Spark. Among the potential uses was sending a reminder to employees to get up and move during the work day, and to inform building maintenance staff whether a bathroom needs cleaning based on usage.

We spend a majority of our lives indoors and these environments have a huge impact on everything from business efficiencies and productivity to our overall wellness, Scanlin said.Physical environments need to be properly equipped to capture, store and access information on how we interact with them, so they can operate like an autonomous nervous system and adjust themselves accordingly.

Milwaukee-based startup Scanalytics Inc. has earned a top award from technology giant Cisco in an IoT for Business development competition.

Joe Scanlin and Matt McCoy founded Milwaukee startup Scanalytics.

Scanalytics, which developed smart flooring technology, earned a first place in the Best Smart Building technology category in the contest, which was held this month at Viva Technology 2017 in Paris. More than 5,000 startups and 68,000 people attended Viva Technology.

Scanalytics has developed a sensor-based engagement and analytics platform that monitors human behavior through foot traffic and predictive analytics. Among the uses the company has tested are retail product sales, in which a salesperson could be alerted if a customer is standing near a product, and business conferences, in which organizers can track booth traffic. The company deployed sensors to more than 100 clients globally in 2016.

Cisco and Scanalytics have now collaborated to create a new use for the smart flooring technology. Joe Scanlin, chief executive officer of Scanalytics, and Petr Bambasek, director of product, worked with Cisco engineers to link its technology to Ciscos Spark cloud collaboration program.

The team created a product through which a chat bot pulls data from Scanalytics application programming interface in real time, and communicates it to a buildings occupants via Spark. Among the potential uses was sending a reminder to employees to get up and move during the work day, and to inform building maintenance staff whether a bathroom needs cleaning based on usage.

We spend a majority of our lives indoors and these environments have a huge impact on everything from business efficiencies and productivity to our overall wellness, Scanlin said.Physical environments need to be properly equipped to capture, store and access information on how we interact with them, so they can operate like an autonomous nervous system and adjust themselves accordingly.

See the rest here:
Scanalytics wins Cisco award - BizTimes.com (Milwaukee)

Facebook Makes a Step Towards Messenger Monetization – nwitimes.com

In order for Messenger to take off financially, Facebook (NASDAQ: FB) needs to "get a lot of businesses using it organically and build the behavior for people that they reach out to businesses for different things," according to CEO Mark Zuckerberg on the last earningscall. Therein lies the real opportunity for Messenger to transform the way that consumers interact with companies.

Earlier this year at its F8 developer conference, Facebook announced a new Discover section for Messenger, which is intended to showcase "amazing experiences" for people and businesses. Yesterday, the social network announced that the Discover section is now rolling out across the U.S. There are different types of things in Discover, like reading articles or getting sports news, but by far the most meaningful from an investing perspective is the potential to introduce users to branded chatbots.

Changing established human behaviors is hard, but there's been a growing trend of users turning to social media to reach customer support. That movement mostly started on Twitter (NYSE: TWTR), but Facebook has a real opportunity here to steal the show and run with it, particularly when it comes to creating a business out of the trend.

When this shift starting nearly a decade ago, there was speculationthat Twitter would start charging businesses that were using its service for customer service. Co-founder Biz Stone penned a blog post shooting down the idea, promising that Twitter would remain free for all accounts (corporate accounts or dedicated support accounts) with existing services. At the time, the company was still trying to brainstorm new services that it could offer companies for a fee, but Stone (who just recently returned to Twitter) said Twitter had no announcements to make then. There is now a small "Provides support" indicator next to official support accounts, but that's about it. Indirectly, support accounts may garner some user data from their interactions that could perhaps be used for ad targeting.

In the years since, Twitter has touted itself as an effective customer service platform -- examples here and here -- but has not announced any new revenue-generating products, which is a huge missed opportunity considering the simple fact that there's always more money in enterprise offerings than consumer ones. So while Twitter has seemingly hit a wall in terms of monetizing the growing trend of social media-based customer service, Facebook not only has an opportunity to become a leader, it also has a more viable route to monetization.

What's less clear is if Facebook is currently charging companies a fee to be included in the new Discover section. Considering how new it is, it wouldn't make much sense to charge. In His Zuckness' words, building that behavior is "the first thing that we need to do on Messenger and WhatsApp." Sending a message directly to a company is but a small behavioral step from tweeting at a company.

Automation has long been the hardest part about scaling up customer service for any organization. The chatbots that Facebook has been developing hope to solve that conundrum once and for all, much to the dismay of the roughly 2.7 million customer service representatives in the U.S. (as of May 2016, accordingto the Bureau of Labor Statistics) that could see their jobs threatened by chatbots.

Rudimentary chatbots have been around for decades, since the dawn of computing in the '50s and '60s. You've probably heard of the Turing test. The big difference between then and now is that the modern generation of chatbots hopes to carry conversations that are more organic and intuitive. They need to be able to follow conversations, understand context, and more. This is no easy task: Facebook's chatbot failure rate was recently estimated at 70%. Let's also not forget Microsoft's experimental chatbot Tay from last year, which was immediately commandeered into a genocidal, racist, sexist murderbot by Twitter trolls.

These are the two critical pieces to this puzzle: Facebook needs to both build up the consumer behavior while tackling the technical challenge of creating compelling chatbots for companies to use. Neither one is easy, but Facebook can work on both concurrently. Importantly, Facebook is not under financial pressure, since its core ad business is booming and shares are trading at all-time highs. Facebook can take its time to make sure it executes. You can't say the same about Twitter.

10 stocks we like better than Facebook

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Facebook wasn't one of them! That's right -- they think these 10 stocks are even better buys.

*Stock Advisor returns as of June 5, 2017

Evan Niu, CFA owns shares of Facebook. Evan Niu, CFA has the following options: long January 2018 $120 calls on Facebook. The Motley Fool owns shares of and recommends Facebook and Twitter. The Motley Fool has a disclosure policy.

See original here:
Facebook Makes a Step Towards Messenger Monetization - nwitimes.com

After vote, Accelerated Genetics slated to merge – La Crosse Tribune

Accelerated Genetics and Select Sires Inc. will be a merged cooperative.

According to a news release, the merger follows a June 22 vote by Accelerate Genetics officials. The vote green-lights an agreement recommended by both companies boards of directors. The smaller Accelerated Genetics has reported financial difficulty in the past. The larger Ohio-based Select Sires will acquire Accelerated Genetics assets, including a bull farm in Westby.

Both companies specialize in artificial insemination of cattle. The companies have an established working relationship that started in 2001 when the companies allied in international markets.

Accelerated Genetics has been searching for a partner who could enhance the business and move it forward, said Scott Dahlk, Accelerated Genetics Board chairman. Joining forces with Select Sires is a positive move for both the member-owners and producers worldwide.

The company said Accelerated Genetics assets, employees and sales representatives will be integrated into the organization. Both companies operate under the cooperative-business model and share similar structures, according to the company.

By working together we will be stronger, said David Thorbahn, Select Sires president and chief executive officer. The value and expertise gained by joining the people from both organizations allow us to offer our customers a broader genetics program in addition to an outstanding animal health product line. Its very exciting to work together, enabling our organizations the ability to expand genetic research, technical support, service, and programs with people who are passionate about the dairy and beef industries.

Link:
After vote, Accelerated Genetics slated to merge - La Crosse Tribune

JPMorgan Checks In On Myriad Genetics Following 30% Rally – Benzinga

Myriad Genetics, Inc.'s (NASDAQ: MYGN) strong run has caught investors attentions, however, JPMorgan analyst Tycho Peterson still doesn't see the stock being able to offset a decline in the hereditary cancer business.

Peterson maintained his Underweight rating and $16 price target.

While in the past, the esoteric LDT market was viewed as sitting at the nexus of the secular shift in healthcare towards personalized medicine, this vision has, in our view, run up against the reality that the LDT business model has a number of challenges, with many labs attempting to support a pharma model centered around heavy rep counts without the benefit of patent protection, Peterson said.

While Peterson expects the stock to fall to $16 - it trades around $25.60 per share - he noted the stock could still move in either direction.

Myriad represents, in our view, a significant opportunity, given near-term catalysts that could drive the stock meaningfully higher or lower, with the setting of FY18 guidance during F4Q earnings (including forward expectations for hereditary cancer) being the most significant upcoming event post-UNH renewal, he said.

However, with its core business in (arguably) structural decline and pipeline that could be long on potential, but short on near-term financial impact, Myriad is not an easy company to value. While we believe the pipeline is intriguing, we do not believe that it can offset what we expect to be a continued steady decline in the core hereditary cancer business.

View More Analyst Ratings for MYGN View the Latest Analyst Ratings

Posted-In: JPMorgan Tycho PetersonAnalyst Color Reiteration Analyst Ratings

2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read more here:
JPMorgan Checks In On Myriad Genetics Following 30% Rally - Benzinga

When Does Life Begin? Pro-Choice ‘Science’ Ignores the Facts. – National Review

When a human egg is fertilized, the result is never a newborn platypus. I didnt need four years of medical school, three years of pediatric residency, three years of neonatal fellowship, and close to two decades of medical practice to tell me that. In fact, high-school biology textbooks explain that all fertilized human eggs (zygotes), after approximately nine months, become newborn human babies unless something occurs to interrupt normal development.

This progression from fertilized egg to newborn is neither alternative science nor a rejection of long-standing medical knowledge. Yet in her paper Alternative Science and Human Reproduction, published this month in the New England Journal of Medicine, R. Alta Charo uses those labels to discredit anyone who acknowledges the biological truth about human development.

Charo attempts in her piece to discredit Donald Trumps pro-life executive-branch appointees. To this end, Charo, who is not a doctor, paints as ludicrous the claim that contraceptives can act as abortifacients by disrupting the natural process of pregnancy and ending a human life.

In reality, the progression of events from sexual intercourse to the creation of new human life is well established.

The process goes something like this: About six days after fertilization of the egg, and multiple cell divisions later, the zygote has become a cluster of cells (now called a morula). It has traversed the mothers fallopian tube and made its way into her uterus, where the process of implantation will then occur over the next four to five days. The various stages of development will continue to unfold until birth. Uterine implantation provides the ideal environmental mix for human development. If either a drug or a device disrupts implantation, the originating events that began approximately six days earlier are stopped, and the pregnancy is prevented from progressing.

So it follows that devices or medications that impede implantation effectively end or abort a pregnancy. This reality contradicts Charos argument that contraceptives abortifacient action is just a politically potent assertion by [Trump] appointees. The potency of the assertion derives from the fact that it is true. As Charo admits, one of the ways contraceptives work is to disrupt implantation.

The government and many physicians, however, define pregnancy as beginning only after implantation. As a physician myself, I prefer not to ignore the physical changes that occur between the moment fertilization occurs and implantation in the mothers womb. According to my embryology textbook, Before We Are Born: Essentials of Embryology and Birth Defects, the zygote represents the beginning of a human being.

From the moment of fertilization, the new human has unique DNA that serves as the cellular blueprint for the duration of his or her entire life. This medical fact does not depend on implantation: It depends entirely on the uniting of the parents DNA. Nor does this fact depend on an elected officials opinion or a lawyers or even a doctors opinion about when life begins.

Admittedly, zygotes dont look like humans. However, at the time of my grandmothers death, she didnt look much like her childhood pictures, and if we could have seen her as an embryo, she would have looked even less like the woman she developed into. But her DNA was intact at fertilization and remained intact throughout her life. My ability to recognize her at various stages of her life did not determine whether or not she was alive. The same is true for prenatal life and postnatal life.

There are multiple medical and legal papers arguing about when we should recognize life the moment we should acknowledge as the beginning of a life and what rights an individual does or does not have at different stages of life. Unfortunately, the arguments on these questions often reflect the ideological agenda of the arguer instead of the medical reality, which is that a unique life is created at fertilization. The distortion of this physiological truth, Charos article notwithstanding, is what makes human reproduction in our era the victim of alternative science.

READ MORE: Little-Known Facts about Roe v. Wade Planned Parenthoods Century of Brutality Planned Parenthoods Annual Report: Abortions Are Up, Prenatal Care Is Down

Robin Pierucci is a wife, a mother of three, and a practicing neonatologist. She is a member of Women Speak for Themselves.

Read the original post:
When Does Life Begin? Pro-Choice 'Science' Ignores the Facts. - National Review

New research on spinal cord repair mechanism in fish can pave way for human spinal cord regeneration – Duke Chronicle

News By Nathan Luzum | Thursday, June 29 Courtesy of Wikimedia Commons

Zebrafish are model organisms to study because they have similargenetic structure to humans.

Zebrafish, a model organism already renowned for its regenerative abilities, has shown promise in yet another area of the fieldspinal regeneration.

Duke researchers discovered that when massive cushioning cells in the zebrafish notochorda precursor to the spine in vertebratesare damaged, another type of cell can find and replace the damaged ones. Because these cushioningor vacuolatedcells are similar betweenfish and humans, the discovery could yield clues with the potential tohelp victims of back or neck pain.

We saw that a cell type surrounding the giant cells moved in to the region of disruption and [was] actually able to replace the giant cells that had been compromised, restoring the notochord structure, wrote Jamie Garcia, graduate student in the School of Medicineand co-first author of the paper.

Michel Bagnat, senior author of the paper and associate professor of cell biology, likened the notochord to a tube. The outside of the notochord, orcasing of the tube, is composed of sheath cells, while the interior houses immense, egg-shaped vacuolated cells. These vacuolated cells account for the notochords ability to cushion and stretch.

However, Bagnat explained, the initial purpose of the research was not to identify a spinal repair mechanism, but rather to explain how the notochord can withstand such heavymechanical stress.

What you have is a very large cell, which is presumably fragile, that is subject to a lot of stress, he said. And then we ask, How is it keeping together?

They first concentrated on caveolaeminuscule pockets of the cell membraneas one possible explanation for the notochord's durability, and discovered that vacuolated cells lacking caveolae collapsed under heavy stress, ceasingto function properly.

We made mutants to basically disrupt [caveolae], and we were expecting that there would be some sort of disruption in these cells, which we found, Bagnat said.

The role of caveolae in the notochord matched the original hypothesis, but the research took an unexpected turnwhen the mutant zebrafish lacking proper caveolae ended up developing a fully formed spine.Bagnat explained that this was because the surrounding sheath cells differentiatedor transformedinto vacuolated cells. Somehow, the released contents of the damaged cell induced nearby sheath cells to replace the damaged structure.

The study is relevant to spinal degeneration in humans, as humans also possessvacuolated cells as shock-absorbing intervertebral discs. These discs can degenerate or become herniated, causing neck or back pain. However, according to the Mayfield Brain and Spine Clinic,nearly 30 percent of people without such pain also have some form of degeneration in intervertebral discs.

The disappearance of the giant vacuolated cells (which are conserved from fish to human) is often associated with degenerative disc disease, Garcia wrote. If we can understand how this basic regeneration process works in fish, we can better understand and possibly implement disc regeneration in humans who experience this condition.

Bagnat noted that a spinal repair mechanism is likely to exist in humans, but whether the process is the same as in zebrafish is unknown at this point.

If there was no repair mechanism, we would probably lose these vacuolated cells out of the center of the intervertebral disc very rapidly, Bagnat said. [However], in fact, we keep them for quite a long time.

Both Bagnat and Garcia explained that one of the labs interests is understanding how the sheath cells receive the necessary instructions to differentiate into a vacuolated cell. Bagnat suspected that the answer may lie in the contents released by a damaged vacuolated cell, sostudying this fluid could answer some major questions concerning disc repair.

If you understand the biology, perhaps you can keep the disc in better shape for a longer time, he said.

The Chronicle is your source for Duke news, sports, culture and dialogue.

Subscribe to the Chronicle: Newsletter | The Dirt | Overtime

Originally posted here:
New research on spinal cord repair mechanism in fish can pave way for human spinal cord regeneration - Duke Chronicle

Mouse brain models reveal insights into genetics of autism – News-Medical.net

June 28, 2017

While the definitive causes remain unclear, several genetic and environmental factors increase the likelihood of autism spectrum disorder, or ASD, a group of conditions covering a "spectrum" of symptoms, skills and levels of disability.

Taking advantage of advances in genetic technologies, researchers led by Alex Nord, assistant professor of neurobiology, physiology and behavior with the Center for Neuroscience at the University of California, Davis, are gaining a better understanding of the role played by a specific gene involved in autism. The collaborative work appears June 26 in the journal Nature Neuroscience.

"For years, the targets of drug discovery and treatment have been based on an unknown black box of what's happening in the brain," said Nord. "Now, using genetic approaches to study the impact of specific mutations found in cases, we're trying to build a cohesive model that links genetic control of brain development with behavior and brain function."

The Nord laboratory studies how the genome encodes brain development and function, with a particular interest in understanding the genetic basis of neurological disorders.

Mouse brain models

There is no known specific genetic cause for most cases of autism, but many different genes have been linked to the disorder. In rare, specific cases of people with ASD, one copy of a gene called CHD8 is mutated and loses function. The CHD8 gene encodes a protein responsible for packaging DNA in cells throughout the body. Packaging of DNA controls how genes are turned on and off in cells during development.

Because mice and humans share on average 85 percent of similarly coded genes, mice can be used as a model to study how genetic mutations impact brain development. Changes in mouse DNA mimic changes in human DNA and vice-versa. In addition, mice exhibit behaviors that can be used as models for exploring human behavior.

Nord's laboratory at UC Davis and his collaborators have been working to characterize changes in brain development and behavior of mice carrying a mutated copy of CHD8.

"Behavioral tests with mice give us information about sociability, anxiety and cognition. From there, we can examine changes at the anatomical and cellular level to find links across dimensions," said Nord. "This is critical to understanding the biology of disorders like autism."

By inducing mutation of the CHD8 gene in mice and studying their brain development, Nord and his team have established that the mice experience cognitive impairment and have increased brain volume. Both conditions are also present in individuals with a mutated CHD8 gene.

New implications for early and lifelong brain development

Analysis of data from mouse brains reveals that CHD8 gene expression peaks during the early stages of brain development. Mutations in CHD8 lead to excessive production of dividing cells in the brain, as well as megalencephaly, an enlarged brain condition common in individuals with ASD. These findings suggest the developmental causes of increased brain size.

More surprisingly, Nord also discovered that the pathological changes in gene expression in the brains of mice with a mutated CHD8 continued through the lifetime of the mice. Genes involved in critical biological processes like synapse function were impacted by the CHD8 mutation. This suggests that CHD8 plays a role in brain function throughout life and may affect more than early brain development in autistic individuals.

While Nord's research centers on severe ASD conditions, the lessons learned may eventually help explain many cases along the autism spectrum.

Collaborating to improve understanding

Nord's work bridges disciplines and has incorporated diverse collaborators. The genetic mouse model was developed at Lawrence Berkeley National Laboratory using CRISPR editing technology, and co-authors Jacqueline Crawley and Jill Silverman of the UC Davis MIND Institute evaluated mouse behavior to characterize social interactions and cognitive impairments.

Nord also partnered with co-author Konstantinos Zarbalis of the Institute for Pediatric Regenerative Medicine at UC Davis to examine changes in cell proliferation in the brains of mice with the CHD8 mutation, and with Jason Lerch from the Mouse Imaging Centre at the Hospital for Sick Children in Toronto, Canada, to conduct magnetic resonance imaging on mouse brains.

"It's the act of collaboration that I find really satisfying," Nord said. "The science gets a lot more interesting and powerful when we combine different approaches. Together we were able to show that mutation to CHD8 causes changes to brain development, which in turn alters brain anatomy, function and behavior."

In the future, Nord hopes to identify how CHD8 packages DNA in neural cells and to determine the specific impacts to early brain development and synaptic function. Nord hopes that deep exploration of CHD8 mutations will ultimately yield greater knowledge of the general factors contributing to ASD and intellectual disability.

Read more from the original source:
Mouse brain models reveal insights into genetics of autism - News-Medical.net